Related Experiment Video
Updated: Sep 13, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Understanding variability in cell death modes and sensitivity: Potential implications for targeted cancer therapies
Magdalena Węgrzyn1, Malgorzata Adamiec-Organisciok1, Anahit Dawicka1
1Department of Systems Biology and Engineering, The Silesian University of Technology, Akademicka Street 16, 44-100, Gliwice, Poland; Biotechnology Centre, Silesian University of Technology, Krzywoustego Street 8, 44-100, Gliwice, Poland.
Regulated cell death (RCD) pathways are crucial for maintaining bodily balance. Understanding RCD variations in tumor cells is key to developing new cancer treatments and improving patient outcomes.
Area of Science:
- Cell Biology
- Oncology
- Physiology
Background:
- Cell death is essential for multicellular organism development and tissue homeostasis.
- Dysregulation of cell death pathways contributes to diseases like cancer, neurodegeneration, and autoimmune disorders.
- Regulated cell death (RCD) encompasses various forms, including apoptosis, necroptosis, and ferroptosis.
Purpose of the Study:
- To review the variability in dominant modes of cell death.
- To examine sensitivity and response pathways across different tumor cell lines.
- To highlight the importance of understanding RCD dynamics for cancer treatment.
Main Methods:
- Literature review of regulated cell death mechanisms.
- Comparative analysis of cell death pathways in various tumor cell lines.
- Synthesis of current knowledge on RCD and cancer.
Main Results:
- Tumor cell lines exhibit diverse sensitivities and responses to different RCD pathways.
- Specific RCD modes may be more dominant or therapeutically relevant in certain cancer types.
- Understanding these variations is critical for targeted therapy development.
Conclusions:
- Variability in RCD pathways presents challenges and opportunities in cancer therapy.
- Tailoring treatments based on tumor-specific RCD profiles can improve efficacy.
- Further research into RCD mechanisms is vital for advancing cancer patient prognosis.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers

